人类猴痘感染的疫苗接种：从基础科学到实际效果
Vaccination for Mpox (Monkeypox) Infection in Humans: From Basic Science to Real-World Effectiveness.
作者信息
See Kay Choong
机构信息
Division of Respiratory and Critical Care Medicine, Department of Medicine, National University Hospital, Singapore 119074, Singapore.
出版信息
Vaccines (Basel). 2024 Oct 8;12(10):1147. doi: 10.3390/vaccines12101147.
Abstract
Human mpox (previously known as monkeypox) is a multi-system disease caused by an orthopox DNA virus [...].
摘要
人猴痘（以前称为猴痘）是一种由正痘DNA病毒引起的多系统疾病[……]
相似文献
1
Vaccination for Mpox (Monkeypox) Infection in Humans: From Basic Science to Real-World Effectiveness.
Vaccines (Basel). 2024 Oct 8;12(10):1147. doi: 10.3390/vaccines12101147.
2
Monkeypox (Mpox) outbreak during COVID-19 pandemic-Past and the future.
J Med Virol. 2023 Apr;95(4):e28701. doi: 10.1002/jmv.28701.
3
[Research progress on the effectiveness of smallpox vaccination against mpox virus infection].
Zhonghua Liu Xing Bing Xue Za Zhi. 2023 Apr 10;44(4):673-676. doi: 10.3760/cma.j.cn112338-20221102-00934.
4
Beyond skin deep: shedding light on the neuropsychiatric consequences of Monkeypox (Mpox).
Acta Neurol Belg. 2024 Aug;124(4):1189-1197. doi: 10.1007/s13760-023-02361-4. Epub 2023 Aug 25.
5
Mpox vaccine and infection-driven human immune signatures: an immunological analysis of an observational study.
Lancet Infect Dis. 2023 Nov;23(11):1302-1312. doi: 10.1016/S1473-3099(23)00352-3. Epub 2023 Jul 17.
6
Treatment and Vaccination for Smallpox and Monkeypox.
Adv Exp Med Biol. 2024;1451:301-316. doi: 10.1007/978-3-031-57165-7_19.
7
CRISPR-Cas12a assisted specific detection of mpox virus.
J Med Virol. 2023 Aug;95(8):e28974. doi: 10.1002/jmv.28974.
8
Mpox (Monkeypox) and the Eye: Ocular Manifestation, Diagnosis, Treatment and Vaccination.
Viruses. 2023 Feb 23;15(3):616. doi: 10.3390/v15030616.
9
Human monkeypox virus in the shadow of the COVID-19 pandemic.
J Infect Public Health. 2023 Aug;16(8):1149-1157. doi: 10.1016/j.jiph.2023.05.013. Epub 2023 May 13.
10
The imperative for quality control programs in Monkeypox virus DNA testing by PCR: CIBERINFEC quality control.
J Med Virol. 2023 Nov;95(11):e29240. doi: 10.1002/jmv.29240.
引用本文的文献
1
Global epidemiology, viral evolution, and public health responses: a systematic review on Mpox (1958-2024).
J Glob Health. 2025 Mar 7;15:04061. doi: 10.7189/jogh.15.04061.
本文引用的文献
1
Orthopoxvirus-specific antibodies wane to undetectable levels 1 year after MVA-BN vaccination of at-risk individuals, the Netherlands, 2022 to 2023.
Euro Surveill. 2024 Sep;29(38). doi: 10.2807/1560-7917.ES.2024.29.38.2400575.
2
Effectiveness of modified vaccinia Ankara-Bavarian Nordic vaccine against mpox infection: emulation of a target trial.
BMJ. 2024 Sep 11;386:e078243. doi: 10.1136/bmj-2023-078243.
3
Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primates.
Cell. 2024 Oct 3;187(20):5540-5553.e10. doi: 10.1016/j.cell.2024.08.043. Epub 2024 Sep 4.
4
Assessment of the knowledge, attitude, and perception of the world's population towards monkeypox and its vaccines: A systematic review and descriptive analysis of cross-sectional studies.
Vaccine X. 2024 Aug 2;20:100527. doi: 10.1016/j.jvacx.2024.100527. eCollection 2024 Oct.
5
Effectiveness of historical smallpox vaccination against mpox clade II in men in Denmark, France, the Netherlands and Spain, 2022.
Euro Surveill. 2024 Aug;29(34). doi: 10.2807/1560-7917.ES.2024.29.34.2400139.
6
Global prevalence and correlates of mpox vaccine acceptance and uptake: a systematic review and meta-analysis.
Commun Med (Lond). 2024 Jul 9;4(1):136. doi: 10.1038/s43856-024-00564-1.
7
Effectiveness and Safety of the MVA-BN Vaccine against Mpox in At-Risk Individuals in the United States (USMVAc).
Vaccines (Basel). 2024 Jun 11;12(6):651. doi: 10.3390/vaccines12060651.
8
Effectiveness of JYNNEOS vaccine against symptomatic mpox disease in adult men in Los Angeles County, August 29, 2022 to January 1, 2023.
Vaccine. 2024 Aug 13;42(20):125987. doi: 10.1016/j.vaccine.2024.05.035. Epub 2024 May 24.
9
Polyvalent mpox mRNA vaccines elicit robust immune responses and confer potent protection against vaccinia virus.
Cell Rep. 2024 Jun 25;43(6):114269. doi: 10.1016/j.celrep.2024.114269. Epub 2024 May 23.
10
Comparison of the immunogenicity and protective efficacy of ACAM2000, MVA, and vectored subunit vaccines for Mpox in rhesus macaques.
Sci Transl Med. 2024 Mar 27;16(740):eadl4317. doi: 10.1126/scitranslmed.adl4317.
Zotero 插件